Total Underwater Colonoscopy (TUC) for Improved Colorectal Cancer Screening: A Randomized Controlled Trial
NCT06333392 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1070
Last updated 2025-12-19
Summary
Colorectal cancer (CRC), the third most diagnosed cancer and second most common cause of cancer death. CRCs develop from precursors like adenomas (about 70% of CRCs) or serrated lesions (SSLs) (about 25-30% of CRCs). Colonoscopy is the cornerstone in CRC screening, in screening programmes often as a work-up examination after a positive primary screening test such as faecal immunochemical test (FIT). Norway and Sweden have recently launched a nationwide faecal haemoglobin CRC screening programmes. Recently, both a Dutch and an Austrian study showed that SSL detection rate (SSLDR) is inversely correlated to CRC at follow-up. Consequently, improved SSLDR can reduce the risk of post-colonoscopy CRC. SSLs are typically located in the right colon. They are flat, with indistinctive boarders, and consequently easily missed or incompletely resected. A Norwegian study showed incomplete resection of 40% of proximal SSLs. The prevalence of SSLs is higher in women than in men, with women being on a threefold risk of developing CRC from SSLs. It seems like post-colonoscopy CRC more often is caused by SSLs than by adenomas. Total underwater colonoscopy (TUC) is a technique replacing conventional CO2 insufflation by water infusion to distend the lumen and visualise the mucosa during withdrawal of the colonoscope and simultaneously removal of water. There are several reasons to advocate TUC:
1. SSLs will be more visible as they "float" on the submucosa and contract into the lumen, while full distension by gas stretches the mucosa, making detection of flat lesions more difficult.
2. Water works like a magnifying lens, making detection and detailed characterisation of lesions easier.
3. uEMR is eased.
4. Improved bowel cleansing
The goal of this clinical trial is to compare colonoscopy outcomes for standard gas (CO2) insufflation and TUC during withdrawal in patients participating in colonoscopy in the Norwegian and Swedish colorectal cancer screening programme after a positive fecal immunochemical test.
The overarching research questions of the present trial is whether colonoscopy outcomes are improved when CO2 insufflation is replaced by TUC during withdrawal and whether the new technique reduces the ecological footprint of the colonoscopy examination.
The project has five main hypotheses:
1. TUC is superior to the standard approach (CO2 withdrawal) regarding detection of proximal SSLs.
2. TUC increases the rate of complete resection of lesions \>= 10mm.
3. TUC reduces the rate of painful colonoscopies and vasovagal reactions.
4. TUC reduces the health care costs by reduced use of single use accessories and reduced number of redundant colonoscopies to obtain polypfree colon.
5. TUC reduces the carbon footprint by reduced use of single use accessories.
If TUC is superior to gas insufflation, the technique may be implemented rapidly since the technique is easy to learn. This study will increase endoscopy competence at participating centres. The centres are involved in national colonoscopy training programs, so the technique will quickly be passed on to other hospitals and screening centres.
The trial can be linked to three of the Global Goals:
* Good health and well-being: The increased detection and improved complete removal of sessile serrated lesions can subsequently decrease the risk of CRC and CRC mortality during follow-up. TUC will probably reduce the rate of painful procedures and vasovagal reactions and thus increase the acceptance of a screening programme. Consequently, the project can contribute significantly to improve screening effectiveness in Norway and Sweden, particularly in women (women have a higher risk for SSLs and a higher risk of colorectal cancer developing from this type of precursor).
* Gender equality: Women have a similar lifetime risk for CRC as men but less benefit of screening regardless of whether they are screened by sigmoidoscopy, FIT or colonoscopy. The reason is probably missed sessile serrated lesions in the proximal colon. If TUC improves SSLDR and complete lesion resection, this may lead to an equal benefit from CRC screening for women and men. Women have also a higher risk of discomfort and pain during colonoscopy than men. It has been shown that women prefer non-invasive screening modalities, potentially to avoid pain during colonoscopy, even if colonoscopy may be the most beneficial screening method for women. If TUC reduces the rate of painful colonoscopies, it can reduce women's barriers to attend screening.
* Responsible consumption and production: The TUC technique will also reduce the ecological footprint of colonoscopy activity due to reduced consumption of single use accessories and reduced number of colonoscopies to achieve polyp free colon. Furthermore, the cost for the health care system will be substantially reduced.
Conditions
- Colorectal Neoplasia
- Screening Colonoscopy
- Colorectal Cancer
- Colorectal Cancer Screening
- Vasovagal Reaction
Interventions
- PROCEDURE
-
Total underwater colonoscopy
one grooup will be randomized to receive a total underwater colonoscopy
- PROCEDURE
-
Conventional colonoscopy
one group will be randomized to undergo a conventional colonoscopy with CO2 withdrawal
Sponsors & Collaborators
-
Ullevaal University Hospital
collaborator OTHER -
Sahlgrenska University Hospital
collaborator OTHER -
Ostfold Hospital Trust
collaborator OTHER -
University Hospital, Akershus
collaborator OTHER -
Vestre Viken Hospital Trust
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 55 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-23
- Primary Completion
- 2026-12-31
- Completion
- 2027-06-30
Countries
- Norway
- Sweden
Study Locations
More Related Trials
-
Stool Sample Collection Study
NCT06294873 ·Status: RECRUITING
-
Prospective Randomized Controlled Trial Comparing Water and Air Colonoscopy in a Community Based Setting
NCT01729416 ·Status: COMPLETED ·Phase: NA
-
Point of Care Faecal Immunochemical Testing for Colorectal Cancer
NCT04402424 ·Status: COMPLETED
-
ColoRectal Cancer Screening for Southern California Community Health Centers
NCT04941300 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficiency of Colon Capsule Endoscopy in Colon Cancer Screening
NCT03052335 ·Status: UNKNOWN ·Phase: NA
-
Impact of Proximal Colon Retroflexion in Colorectal Cancer Screening Programme
NCT03041532 ·Status: COMPLETED ·Phase: NA
-
Uptake to Colorectal Cancer Screening in Familial-risk Population
NCT02567045 ·Status: COMPLETED ·Phase: NA
-
Comparative Study of Colon Capsule and Virtual Colonoscopy (VICOCA)
NCT02081742 ·Status: COMPLETED
-
Faecal Immunochemical Tests (FIT) for Surveillance After Colorectal Cancer (CRC) Study
NCT06689293 ·Status: RECRUITING
-
Screening for Colorectal Cancer With FOBT, Virtual Colonoscopy and Optical Colonoscopy. A Randomized Clinical Trial in the Florence District
NCT01651624 ·Status: COMPLETED ·Phase: NA
-
Artificial Intelligence-Assisted Colonoscopy in Colorectal Cancer Screening in a General Hospital
NCT06792292 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening
NCT02738359 ·Status: COMPLETED
-
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
NCT05994482 ·Status: RECRUITING
-
Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
NCT01239082 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Colorectal Cancer: Screening vs. Non-Screening
NCT02727894 ·Status: COMPLETED
-
Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection
NCT06703632 ·Status: RECRUITING ·Phase: NA
-
Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers
NCT03563651 ·Status: COMPLETED
-
Effectiveness of Using Mobile Health Technology in Colorectal Cancer Screening Uptake
NCT06192862 ·Status: COMPLETED ·Phase: NA
-
Combining Risk Factors and Faecal Immunochemical Testing in Colorectal Cancer Screening: a Randomized Controlled Trial
NCT04490551 ·Status: COMPLETED ·Phase: NA
-
FOcUs on Colorectal CAncer oUtcomes: Long-Term Study
NCT03965325 ·Status: COMPLETED
-
Non-cathartic Computed Tomographic Colonography to Screen Subjects With a Family History of Colorectal Cancer
NCT01766479 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT00843375 ·Status: RECRUITING
-
Comparative Effectiveness of CTC & OC
NCT02143115 ·Status: COMPLETED
-
Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC
NCT04912882 ·Status: NOT_YET_RECRUITING
-
Colonic Stent and Tumor Cell Dissemination
NCT01628328 ·Status: COMPLETED